Aldehyde Dehydrogenase 1 in Gastric Cancer

Overview

Journal J Oncol

Specialty Oncology

Date 2022 Mar 21

PMID 35310914

Authors

Ling Wang

Luosha Wang

Yang Yu

Ruiliang Su

Yating Zhang

Yumin Li

Mingde Zang

Affiliations

Soon will be listed here.

Abstract

Gastric cancer (GC) is a disease that threatens human health. It is thus crucial to clarify the mechanisms involved in GC development and discover diagnostic biomarkers and therapeutics. As a cancer stem cell marker, aldehyde dehydrogenase 1 (ALDH1) is involved in the development, progression, and treatment of GC. This review evaluated the prognostic value of ALDH1 and explored its mechanism of action in GC. Importantly, ALDH1 is an informative biomarker in clinical practice as it has specific relationships with indicators, such as metastasis and overall survival. Additionally, ALDH1 interacts with genes and exhibits properties that mimic stem cell characteristics amongst other mechanisms employed in the occurrence and progression of GC. Our results, therefore, provide evidence of possible clinical utility of ALDH1 as a GC therapeutic target.

Citing Articles

Study on the value of gastrin 17 and aldehyde dehydrogenase 1 in gastric juice for early diagnosis in gastric cancer.

Wang Y, Liu H, Li X, Jin J, Yan B Front Oncol. 2025; 15:1521868.

PMID: 39959662 PMC: 11825325. DOI: 10.3389/fonc.2025.1521868.

The Significance of Aldehyde Dehydrogenase 1 in Cancers.

Nguyen A, Facey C, Boman B Int J Mol Sci. 2025; 26(1.

PMID: 39796106 PMC: 11720537. DOI: 10.3390/ijms26010251.

[SWI/SNF Complex Gene Mutations Promote the Liver Metastasis  of Non-small Cell Lung Cancer Cells in NSI Mice].

Gao L, Xie Z, Lin S, Lv Z, Zhou W, Chen J Zhongguo Fei Ai Za Zhi. 2023; 26(10):753-764.

PMID: 37989338 PMC: 10663775. DOI: 10.3779/j.issn.1009-3419.2023.102.35.

The Clinical Significance and Prognostic Value of ALDH1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.

Li D, Cao Y, Luo C, Zhang L, Zou Y Recent Pat Anticancer Drug Discov. 2023; 19(5):599-609.

PMID: 37818578 DOI: 10.2174/0115748928265992230925053308.

ALDH1: A potential therapeutic target for cancer stem cells in solid tumors.

Wei Y, Li Y, Chen Y, Liu P, Huang S, Zhang Y Front Oncol. 2022; 12:1026278.

PMID: 36387165 PMC: 9650078. DOI: 10.3389/fonc.2022.1026278.

References

Giraud J, Molina-Castro S, Seeneevassen L, Sifre E, Izotte J, Tiffon C . Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells. Int J Cancer. 2019; 146(8):2255-2267. DOI: 10.1002/ijc.32667. View

Huang R, Li X, Holm R, Trope C, Nesland J, Suo Z . The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study. BMC Cancer. 2015; 15:502. PMC: 4494797. DOI: 10.1186/s12885-015-1513-5. View

Ricci-Vitiani L, Lombardi D, Pilozzi E, Biffoni M, Todaro M, Peschle C . Identification and expansion of human colon-cancer-initiating cells. Nature. 2006; 445(7123):111-5. DOI: 10.1038/nature05384. View

Katsuno Y, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K . Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β. J Pathol. 2012; 228(3):391-404. DOI: 10.1002/path.4020. View

Zhi Q, Chen X, Ji J, Zhang J, Li J, Cai Q . Salinomycin can effectively kill ALDH(high) stem-like cells on gastric cancer. Biomed Pharmacother. 2011; 65(7):509-15. DOI: 10.1016/j.biopha.2011.06.006. View

Wang S, Zheng R, Zhang S, Zeng H, Chen R, Sun K . [Epidemiological characteristics of gastric cancer in China, 2015]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 40(12):1517-1521. DOI: 10.3760/cma.j.issn.0254-6450.2019.12.003. View

Vassalli G . Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells. Stem Cells Int. 2019; 2019:3904645. PMC: 6348814. DOI: 10.1155/2019/3904645. View

Sun J, Sun B, Zhu D, Zhao X, Zhang Y, Dong X . HMGA2 regulates CD44 expression to promote gastric cancer cell motility and sphere formation. Am J Cancer Res. 2017; 7(2):260-274. PMC: 5336500. View

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

10.

Chute J, Muramoto G, Whitesides J, Colvin M, Safi R, Chao N . Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci U S A. 2006; 103(31):11707-12. PMC: 1544234. DOI: 10.1073/pnas.0603806103. View

11.

Han S, Huang T, Wu X, Wang X, Li W, Liu S . Prognostic value of ALDH1 and Nestin in advanced cancer: a systematic meta-analysis with trial sequential analysis. Ther Adv Med Oncol. 2019; 11:1758835919830831. PMC: 6393950. DOI: 10.1177/1758835919830831. View

12.

Gong X, Xu B, Zi L, Chen X . miR-625 reverses multidrug resistance in gastric cancer cells by directly targeting ALDH1A1. Cancer Manag Res. 2019; 11:6615-6624. PMC: 6643062. DOI: 10.2147/CMAR.S208708. View

13.

Tsunedomi R, Yoshimura K, Suzuki N, Hazama S, Nagano H . Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact. Surg Today. 2020; 50(12):1560-1577. DOI: 10.1007/s00595-020-01968-x. View

14.

He Q, Luo X, Wang K, Zhou Q, Ao H, Yang Y . Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas. Cell Physiol Biochem. 2014; 33(1):173-84. DOI: 10.1159/000356660. View

15.

Wakamatsu Y, Sakamoto N, Oo H, Naito Y, Uraoka N, Anami K . Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol Int. 2012; 62(2):112-9. DOI: 10.1111/j.1440-1827.2011.02760.x. View

16.

Ekinci E, Rohondia S, Khan R, Dou Q . Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents. Recent Pat Anticancer Drug Discov. 2019; 14(2):113-132. DOI: 10.2174/1574892814666190514104035. View

17.

Cao X, Ren K, Song Z, Li D, Quan M, Zheng Y . 7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells. Oncol Rep. 2016; 36(2):1157-65. DOI: 10.3892/or.2016.4848. View

18.

Piazuelo M, Correa P . Gastric cáncer: Overview. Colomb Med (Cali). 2014; 44(3):192-201. PMC: 4002033. View

19.

Levi E, Sochacki P, Khoury N, Patel B, Majumdar A . Cancer stem cells in Helicobacter pylori infection and aging: Implications for gastric carcinogenesis. World J Gastrointest Pathophysiol. 2014; 5(3):366-72. PMC: 4133534. DOI: 10.4291/wjgp.v5.i3.366. View

20.

Liau B, Sievers C, Donohue L, Gillespie S, Flavahan W, Miller T . Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. Cell Stem Cell. 2016; 20(2):233-246.e7. PMC: 5291795. DOI: 10.1016/j.stem.2016.11.003. View